Bank of New York Mellon’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-585
| Closed | -$7.33K | – | 4106 |
|
|
2024
Q3 | $7.33K | Hold |
585
| – | – | ﹤0.01% | 4073 |
|
|
2024
Q2 | $8.54K | Sell |
585
-12,229
| -95% | -$179K | ﹤0.01% | 4097 |
|
|
2024
Q1 | $287K | Sell |
12,814
-879
| -6% | -$19.7K | ﹤0.01% | 3785 |
|
|
2023
Q4 | $259K | Hold |
13,693
| – | – | ﹤0.01% | 3855 |
|
|
2023
Q3 | $234K | Hold |
13,693
| – | – | ﹤0.01% | 3901 |
|
|
2023
Q2 | $411K | Buy |
13,693
+11,592
| +552% | +$348K | ﹤0.01% | 3692 |
|
|
2023
Q1 | $61.5K | Hold |
2,101
| – | – | ﹤0.01% | 4158 |
|
|
2022
Q4 | $41.5K | Hold |
2,101
| – | – | ﹤0.01% | 4263 |
|
|
2022
Q3 | $64K | Hold |
2,101
| – | – | ﹤0.01% | 4279 |
|
|
2022
Q2 | $48K | Sell |
2,101
-13,072
| -86% | -$299K | ﹤0.01% | 4350 |
|
|
2022
Q1 | $679K | Buy |
15,173
+649
| +4% | +$29K | ﹤0.01% | 3527 |
|
|
2021
Q4 | $559K | Buy |
14,524
+247
| +2% | +$9.51K | ﹤0.01% | 3736 |
|
|
2021
Q3 | $724K | Buy |
14,277
+985
| +7% | +$50K | ﹤0.01% | 3588 |
|
|
2021
Q2 | $1.16M | Buy |
13,292
+11,191
| +533% | +$974K | ﹤0.01% | 3308 |
|
|
2021
Q1 | $94K | Buy |
+2,101
| New | +$94K | ﹤0.01% | 4171 |
|